Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep;15(3):649-56.
doi: 10.1677/ERC-08-0043. Epub 2008 Jun 4.

Endocrine Disruptors and Prostate Cancer Risk

Affiliations
Free PMC article
Review

Endocrine Disruptors and Prostate Cancer Risk

Gail S Prins. Endocr Relat Cancer. .
Free PMC article

Abstract

There is increasing evidence both from epidemiology studies and animal models that specific endocrine-disrupting compounds may influence the development or progression of prostate cancer. In large part, these effects appear to be linked to interference with estrogen signaling, either through interacting with ERs or by influencing steroid metabolism and altering estrogen levels within the body. In humans, epidemiologic evidence links specific pesticides, PCBs and inorganic arsenic exposures to elevated prostate cancer risk. Studies in animal models also show augmentation of prostate carcinogenesis with several other environmental estrogenic compounds including cadmium, UV filters and BPA. Importantly, there appears to be heightened sensitivity of the prostate to these endocrine disruptors during the critical developmental windows including in utero and neonatal time points as well as during puberty. Thus infants and children may be considered a highly susceptible population for ED exposures and increased risk of prostate cancers with aging.

Conflict of interest statement

Declaration of interest

The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.

Similar articles

See all similar articles

Cited by 38 articles

See all "Cited by" articles

Publication types

Feedback